Merck said its board authorized an additional $10 billion share repurchase authorization, which has no time limit for completion. The maker of medicines and vaccines has a market cap of $247.75 ...

Merck (MRK) announced that the board of directors has declared a quarterly dividend of 81c per share of the company’s common stock for the second quarter of 2025. Payment will be made on April 7 ...

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. The company provides property, casualty, life, accident ...

Residents working with UAE-based corporates and government organisations are invited to take a complimentary diabetes screening and health consultation at Merck’s booth, supported by local healthcare ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

During an R&D update yesterday Merck said it is hoping to claim eight new cardiovascular therapy approvals between now and 2030, for diseases like atherosclerosis, heart failure, pulmonary ...

Cyrus Massoumi, founder of Dr. B, tells us about his online platform ... Pfizer’s Paxlovid and Merck & Co’s Molnupiravir are two oral antiviral treatments authorised for patients with mild ...

Welireg generated $139 million in sales during 2024’s third quarter and is the only approved HIF-2α inhibitor in the U.S. Merck’s application ... oral factor B inhibitor Fabhalta in the ...

Molson Coors Beverage Co. Cl A 0.00% $11.14B Molson Coors Beverage Co. Cl B-3.12% $11.67B ...

(The Center Square) – Arguments are scheduled in the North Carolina Supreme Court in two weeks and the election for Seat 6 on its bench remains undecided. A litigation addendum to the Nov. 5 ...

Pre-Market: 5:02:09 a.m. EST ...